BRÈVE

sur SynBiotic SE (isin : DE000A3E5A59)

European Hemp and Cannabis Developments Highlighted at ICBC Berlin

SYNBIOTIC SE, a significant player in the European cannabis sector, and GOC NEXUS, known for their microbiological decontamination processes, will present at the International Cannabis Business Conference (ICBC) in Berlin on April 29-30. Their collaboration, initiated in December 2024, focuses on advancing medicinal cannabis standards.

CEO Daniel Kruse advocates for maintaining cannabis as medicine amidst potential political changes following Germany’s 2025 federal election. He emphasizes the importance of industrial hemp in job creation, urging action against legal hurdles, particularly the ‘intoxication clause’ which hampers industry growth.

With Germany’s recent cannabis legalization, the market could surpass one billion euros by 2028, but political shifts risk stalling this progress. SYNBIOTIC plans to introduce a new medicinal cannabis dosage form, amidst its current strong performance figures.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de SynBiotic SE